3-aminobenzamide has been researched along with cladribine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bilgeri, R; Geisen, FH; Haun, M; Konwalinka, G; Petzer, AL; Schirmer, M; Zilian, U | 1 |
| Cawley, JC; Pettitt, AR; Sherrington, PD | 1 |
2 other study(ies) available for 3-aminobenzamide and cladribine
| Article | Year |
|---|---|
Effect of deoxycytidine on 2-chloro-deoxyadenosine-mediated growth inhibition of normal human erythroid and myeloid progenitor cells.
Topics: Benzamides; Bone Marrow; Bone Marrow Cells; Cell Division; Cells, Cultured; Cladribine; Deoxycytidine; Dose-Response Relationship, Drug; Erythroid Precursor Cells; Hematopoiesis; Hematopoietic Stem Cells; Humans; Trypsin Inhibitors | 1993 |
Role of poly(ADP-ribosyl)ation in the killing of chronic lymphocytic leukemia cells by purine analogues.
Topics: Antineoplastic Agents; Benzamides; Cell Death; Cell Membrane; Cell Size; Cladribine; DNA Fragmentation; Drug Interactions; Drug Resistance, Neoplasm; Enzyme Inhibitors; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Tumor Suppressor Protein p53; Vidarabine | 2000 |